Navigation Links
Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
Date:2/27/2008

r therapies.

Safety findings in the study were manageable and consistent with prior Phase II studies. Common adverse events in the study included mouth ulcers, high blood lipids, high blood sugar, skin rash, low red blood count, low phosphate levels, and inflammation of the lungs.

About Everolimus

Everolimus, an oral inhibitor of mTOR, is an investigational drug being studied in multiple tumor types. In cancer cells, everolimus inhibits mTOR, a protein that acts as a central regulator of tumor cell division, cell metabolism and blood vessel growth. Everolimus is a once-daily oral therapy that provides continuous inhibition of mTOR.

As an investigational compound, the safety and efficacy profile of everolimus has not yet been established in oncology. Access to everolimus is available only through carefully controlled and monitored clinical trials. These trials are designed to better understand the potential benefits and risks of the compound. Because of the uncertainty of clinical trials, there is no guarantee that everolimus will ever be commercially available for oncology indications anywhere in the world. Everolimus is approved under the trade-name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first approved in the EU in 2003 and is available in more than 60 countries.

Disclaimer

The foregoing release contains forward-looking statements that can be identified by terminology such as "to be", "planned", "may", "offers", "potential", "could", "possibilities", "will", or similar expressions, or by express or implied discussions regarding potential future approvals for everolimus or regarding potential future revenues from everolimus. Such forward-looking statements reflect the current views of the Company regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results with everolimus to be materially differen
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
2. Phase I and Phase I/II DCVax(R)-Brain Data Continues to Show Significantly Improved Survival Rates for Brain Cancer Patients
3. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
4. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
5. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
6. Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis
7. New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings
8. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
9. CV Therapeutics Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36
10. VIA Pharmaceuticals Presents Data at American Heart Association Meeting Showing VIA-2291 Significantly Reduces Inflammation in Preclinical Model of Atherosclerosis
11. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015  PROMETRIKA, LLC, ... its offerings with the addition of pharmacovigilance services ... world leader in safety data collection and reporting, ... regulatory affairs professionals, and expert physicians, each with ... clinical interpretation and monitoring of safety trends. ...
(Date:6/2/2015)... Mass. , June 2, 2015  Psychemedics Corporation ... leader for over twenty-five years, announced the addition of ... In response to growing abuse concerns, the addition of ... and D-Amphetamine/Adderall® was added as an option to the ... Chairman and CEO stated:  "Sadly, more and more prescription ...
(Date:6/2/2015)... 2015  Accuray Incorporated (Nasdaq: ARAY ), announced ... at the Goldman Sachs 36th Annual Global Healthcare Conference ... on Wednesday, June 10, 2015 at 4:00pm PT.   ... be available on the Investor Relations page of the ... of the presentation will begin approximately one hour after ...
Breaking Medicine Technology:PROMETRIKA Announces the Availability of Pharmacovigilance Services 2Psychemedics Announces Addition Of FDA Cleared Drugs 2Psychemedics Announces Addition Of FDA Cleared Drugs 3
... (Nasdaq: NBIX ) today announced the pricing ... its common stock at a price to the public ... from this offering, before deducting underwriting discounts and commissions ... to be approximately $77 million. The offering is expected ...
... 19, 2012  The Catalina Council of the Boy Scouts ... Arizona will complete the Chemistry Merit Badge requirements through ... based in Oro Valley, Arizona. Boy Scout participants will ... biologists and chemists, under whose guidance they can participate ...
Cached Medicine Technology:Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock 2Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock 3Catalina Council Boy Scouts Partner With Sanofi US Tucson Research Center to Host First-Ever Chemistry Merit Badge Program 2Catalina Council Boy Scouts Partner With Sanofi US Tucson Research Center to Host First-Ever Chemistry Merit Badge Program 3
(Date:6/2/2015)... NC (PRWEB) June 02, 2015 Food ... hosting its sixth annual “Thriller on the Griller” events, ... Carolina and South Carolina locations. Each event will raise ... dedicated to restoring a sense of self, restoring the ... and our military families. , Through these events, ...
(Date:6/2/2015)... Highly qualified dental care specialists inside the leading ... change in the dental tourism industry in Europe. As dentistry ... offers a full range of superior dental services in its ... , Partnered with a top medical tourism agency , ... and has earned a reputation as an influential provider for ...
(Date:6/2/2015)... The term “Augmented Reality” was coined ... on the real world. Since then many promising technologies ... a map of the vasculature on the surface of ... , AccuVein, the leader in vein visualization, exemplifies this ... and such widespread adoption of its AccuVein AV400 devices ...
(Date:6/2/2015)... 02, 2015 “ Radaris ” was featured ... a look at the latest and coolest applications on the ... of AppWatch and technology expert, conducted the app review and ... they need on a person. , According to Psychology Today, ... goes on to explain that curiosity is a part of ...
(Date:6/2/2015)... FL (PRWEB) June 02, 2015 MedPro ... staffing services to healthcare facilities, today announced the worldwide ... and effective mobile tool to help candidates find best ... Glassdoor survey released in 2014, 9 in 10 job ... during their job search. , The MedPro Top Jobs ...
Breaking Medicine News(10 mins):Health News:Food Lion to Launch “Thriller on the Griller” Events to Benefit Military Families through Hope For The Warriors® 2Health News:Food Lion to Launch “Thriller on the Griller” Events to Benefit Military Families through Hope For The Warriors® 3Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 2Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 3Health News:Vein Visualization Emerges as Premier Augmented Reality Application 2Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:MedPro Healthcare Staffing Launches New MedPro Top Jobs App To Facilitate Job Search For Healthcare Professionals 2
... A scientist at the Hebrew University of Jerusalem,s Robert ... succeeded in producing a replica of human collagen from ... for use in a variety of human medical procedures. ... most abundant protein in the human body and is ...
... Glasgow, UK 10 June, 2010 Further results from the ... for the first time today at the 6th Research Congress ... , The survey, which is the first international survey ... a patient perspective, show that up to 45% of cancer ...
... nerves in the spinal cord normally cannot grow back and ... enable nerve regrowth. Publishing online this week in the Early ... Sciences, researchers at the Johns Hopkins University School of ... enzyme, sialidase, improves nerve regrowth, motor recovery and nervous system ...
... Society for Radiation Oncology (ASTRO) has been named to ... outstanding work on its public awareness campaign to help ... In September 2003, ASTRO conducted a national survey to ... determined that the public knew very little about this ...
... Joshua Niska, a 5-year intern at the Translational Genomics ... today by being named one of the nation,s top 20 ... of the national newspaper,s 2010 All-USA College Academic (First) Team ... according to the newspaper, based on their leadership, activities and, ...
... A thesis from the University of Gothenburg, Sweden, reveals ... across to young people, but also points out that ... products. A thesis from the University of Gothenburg ... teaching with a focus on fish are achieving results. ...
Cached Medicine News:Health News:Collagen manufactured from transgenic tobacco plants at Hebrew University 2Health News:European patient survey add weight to expert call for greater clinical consensus on BTCP 2Health News:Improving recovery from spinal cord injury 2Health News:ASTRO patient education program recognized by AAA Awards 2Health News:TGen intern named one of nation's top 20 students by USA Today 2Health News:TGen intern named one of nation's top 20 students by USA Today 3Health News:Changing young people's eating habits 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: